4//SEC Filing
THURMAN RANDY H 4
Accession 0001213900-20-037060
CIK 0001733413other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 9:01 PM ET
Size
10.3 KB
Accession
0001213900-20-037060
Insider Transaction Report
Form 4
THURMAN RANDY H
Director
Transactions
- Exercise/Conversion
Common Stock
2020-11-11$2.50/sh+34,504$86,260→ 39,504 total - Sale
Common Stock
2020-11-11$15.91/sh−34,504$548,890→ 5,000 total - Sale
Common Stock
2020-11-13$17.17/sh−5,000$85,865→ 0 total - Exercise/Conversion
Stock Options (Right to Buy)
2020-11-11−34,504→ 124,925 totalExercise: $2.50From: 2020-04-11Exp: 2029-04-11→ Common Stock (34,504 underlying)
Footnotes (2)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F2]23,003 shares of common stock vested on April 11, 2020 and the remainder of shares scheduled to vest at an approximate rate of 5,750 every three months thereafter.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001204059
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 9:01 PM ET
- Size
- 10.3 KB